TI
ABMD

Turner Investments’s Abiomed Inc ABMD Stock Holding History

Turner Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-750
Closed -$126K – 71
2017
Q3 		$126K Sell
750
-8,850
-92% -$1.34M 0.57% 71
2017
Q2 		$1.38M Buy
9,600
+400
+4% +$53.8K 0.9% 37
2017
Q1 		$1.15M Sell
9,200
-10,800
-54% -$1.25M 0.75% 53
2016
Q4 		$2.25M Buy
20,000
+3,000
+18% +$348K 0.91% 26
2016
Q3 		$2.19M Sell
17,000
-22,000
-56% -$2.64M 0.72% 52
2016
Q2 		$4.26M Buy
39,000
+16,000
+70% +$1.59M 1.34% 21
2016
Q1 		$2.18M Buy
23,000
+2,500
+12% +$211K 0.59% 57
2015
Q4 		$1.85M Sell
20,500
-18,500
-47% -$1.57M 0.38% 81
2015
Q3 		$3.62M Buy
39,000
+11,010
+39% +$970K 0.73% 52
2015
Q2 		$1.84M Buy
27,990
+18,540
+196% +$1.23M 0.34% 102
2015
Q1 		$676K Sell
9,450
-10,760
-53% -$584K 0.12% 196
2014
Q4 		$769K Buy
+20,210
New +$637K 0.09% 309

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Turner Investments's ABMD Position: Q4 2017 in Review

Turner Investments sold out of Abiomed Inc (ABMD) in Q4 2017, closing a stake of 750 shares — an estimated $126K sold.

Turner Investments first reported a position in ABMD in Q4 2014 and held it in 12 quarters. The position peaked at $4.26M in Q2 2016. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Turner Investments reported no remaining Abiomed Inc position as of Q4 2017 after selling out during the quarter.
  • Turner Investments sold 750 Abiomed Inc shares in Q4 2017, an estimated $126K.
  • Turner Investments first reported a position in Abiomed Inc in Q4 2014 and held it in 12 quarters.
  • Turner Investments's Abiomed Inc position peaked at $4.26M in Q2 2016.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.